TY - CONF
T1 - Non-myeloablative hematopoietic stem cell transplantation (HSCT) is superior to disease modifying drug (DMD) treatment in highly active Relapsing Remitting Multiple Sclerosis (RRMS): interim results of the Multiple Sclerosis International Stem cell Transplant (MIST) Randomized Trial
JO - NEUROLOGY
PY - 2018/04/10
AU - Burt RK
AU - Balabanov R
AU - Snowden JA
AU - Sharrack B
AU - Oliveira MC
AU - Burman J
ED -
VL - 90
Y2 - 2025/01/02
ER -